From Lenskart’s muted debut to Groww’s strong listing, India’s IPO market is buzzing again — but with mixed signals. Over the past three decades, an IPO boom has always been followed by a bust. Will ...
US cancer biotech bluebird bio has joined with TC BioPharm in a collaboration focused on gamma delta CAR-T cells. As reported by pharmaphorum earlier this year, TC BioPharm has already won EU funding ...
Scientific American is the essential guide to the most awe-inspiring advances in science and technology, explaining how they change our understanding of the world and shape our lives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback